Absorbable Hemostats Market Size Forecast To Achieve $4.95 Billion By 2030 With 8.1% CAGR

Global Absorbable Hemostats Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Absorbable Hemostats Market During The Forecast Period?

The absorbable hemostats market has experienced robust expansion over recent years. Its projected growth is from $3.37 billion in 2025 to $3.63 billion in 2026, advancing at a compound annual growth rate (CAGR) of 7.8%. This historical expansion can be linked to several factors, including a greater number of neurosurgery and orthopedic surgery procedures, an elevated need for intraoperative bleeding management solutions, the wider acceptance of oxidized regenerated cellulose and gelatin-based hemostats, the enlargement of hospital surgical facilities and operating rooms, and the enhanced clinical approval of absorbable biomaterial hemostats.

The absorbable hemostats market is projected to experience robust expansion in the coming years. This market is anticipated to reach $4.96 billion by 2030, progressing at a compound annual growth rate (CAGR) of 8.1%. This anticipated growth during the forecast period is fueled by several factors, including the increasing application of advanced thrombin and collagen-based formulations, a growing inclination towards minimally invasive and reconstructive surgical procedures, heightened investment in bioabsorbable and hybrid hemostat innovations, an expansion in the number of procedures performed at ambulatory surgical centers, and a greater emphasis on minimizing surgical complications and recovery periods. Key trends emerging within this period involve the accelerating development of bioengineered absorbable hemostat materials designed for improved tissue compatibility, the increasing integration of advanced collagen, gelatin, and thrombin-based hemostats in intricate surgical operations, a rising demand for multifunctional hemostatic solutions that aid in swift clot stabilization and wound healing, the expanding application of absorbable hemostats in both minimally invasive and reconstructive surgeries, and a heightened clinical emphasis on hemostats specifically formulated to mitigate post-operative complications and surgical bleeding risks.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18777&type=smp

Which Drivers Are Advancing The Absorbable Hemostats Market Growth?

The escalating number of surgical procedures is projected to drive the future expansion of the absorbable hemostats market. Surgical procedures involve medical operations undertaken to diagnose, treat, or manage various conditions by physically altering tissues or organs through incisions or alternative techniques. This rise in surgical procedures stems from an escalating demand for advanced medical treatments, an aging global population, and progress in surgical technology enabling more complex and minimally invasive interventions. Absorbable hemostats play a crucial role in surgical procedures by controlling bleeding and fostering clot formation, all while being gradually assimilated by the body. This attribute diminishes the necessity for subsequent interventions and reduces postoperative complications. For instance, in April 2025, data from the British Association of Aesthetic Plastic Surgeons, a professional organization based in the UK, indicated that a total of 25,972 surgical procedures were performed in 2023. Women constituted 93% of these cosmetic surgeries, with men accounting for the remaining 7% of cases. Therefore, the growing volume of surgical procedures is a key factor propelling the growth of the absorbable hemostasis market.

How Is The Absorbable Hemostats Market Distributed Across Key Segments?

The absorbable hemostats market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Other Types

2) By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Other Applications

3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Thrombin-Based Hemostats: Lyophilized Thrombin Hemostats, Liquid Thrombin-Based Hemostats

2) By Oxidized Regenerated Cellulose-Based Hemostats: Pre-Packaged Oxidized Cellulose Hemostats, Customizable Oxidized Cellulose Products

3) By Gelatin-Based Hemostats: Gelatin Sponge-Based Hemostats, Gelatin Foam-Based Hemostats

4) By Collagen-Based Hemostats: Collagen-Based Pads or Sheets, Collagen-Based Sponges or Powder

5) By Other Types: Fibrin-Based Hemostats, Polymeric-Based Hemostats, Other Innovative Or Hybrid Formulations

Which Trends Are Guiding The Development Of The Absorbable Hemostats Market?

Major companies in the absorbable hemostats market are concentrating on creating sophisticated solutions, such as absorbable hemostatic powder, to ensure swift and efficient bleeding management during surgical procedures. This medical product is designed to manage hemorrhage by facilitating rapid clot development at the injury site, subsequently being naturally absorbed by the body once its purpose is fulfilled. An illustrative example is Baxter International Inc., a US-based healthcare firm, which introduced PERCLOT absorbable hemostatic powder in July 2023. PERCLOT granules are characterized by a distinct molecular architecture that quickly draws in water, forming a gel-like adhesive matrix. This matrix establishes a physical impediment to bleeding by encouraging the aggregation of platelets, red blood cells, and crucial coagulation proteins such as thrombin and fibrinogen. Such an attribute significantly boosts clinicians’ capacity to address a wider array of intraoperative bleeding scenarios, which is vital for decreasing the requirement for blood transfusions, mitigating severe complications, and ultimately diminishing the total expense of medical care.

Which Key Players Are Active In The Absorbable Hemostats Market?

Major companies operating in the absorbable hemostats market are Johnson & Johnson, Medtronic Plc, Baxter International Inc., B. Braun Melsungen AG, Integra LifeSciences, Acelity, Meril Life Sciences Pvt. Ltd., Gelita AG, CryoLife Inc., Anika Therapeutics Inc., Z-Medica LLC, Cohera Medical Inc., Marine Polymer Technologies Inc., Curasan AG, Hemostasis LLC, Arch Therapeutics Inc., Cura Medical, FzioMed Inc., Guizhou Jin Jiu Biotech Co. Ltd., Omrix Biopharmaceuticals Inc.

Access The Complete Absorbable Hemostats Market Report:

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Which Region Accounts For The Highest Share Of The Absorbable Hemostats Market?

North America was the largest region in the absorbable hemostats market in 2025. The regions covered in the absorbable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Absorbable Hemostats Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=18777&type=smp

Browse Through More Reports Similar to the Global Absorbable Hemostats Market 2026, By The Business Research Company

Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hemostasis Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model